We are live on
!
Find out more
DCM
DG Capital Management Portfolio holdings
AUM
$326M
1-Year Est. Return
39.67%
This Fund
S&P 500
This Quarter
Est. Return
+6.54%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
–
AUM
$224M
AUM Growth
+$46.4M
(+26%)
Cap. Flow
+$30.3M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
67.35%
Holding
41
New
11
Increased
9
Reduced
7
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$12.5M |
| 2 |
Community Health Systems
CYH
|
+$7.24M |
| 3 |
ATSG
Air Transport Services Group
ATSG
|
+$5.43M |
| 4 |
FerroAtlántica
GSM
|
+$3.2M |
| 5 |
VEON
VEON
|
+$3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$8.78M |
| 2 |
United Therapeutics
UTHR
|
+$8.13M |
| 3 |
Turning Point Brands
TPB
|
+$5.3M |
| 4 |
Tenet Healthcare
THC
|
+$3.8M |
| 5 |
Anterix
ATEX
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.45% |
| 2 | Consumer Discretionary | 23.21% |
| 3 | Industrials | 11.77% |
| 4 | Communication Services | 6.33% |
| 5 | Financials | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tenet Healthcare
THC
$22.6B
| $25.6M | 11.4% |
314,196
-53,367
| -15% | -$3.8M |
|
2
Hertz
HTZ
$556M
| $20.9M | 9.31% |
1,135,186
+60,000
| +6% | +$983K |
|
3
Caesars Entertainment
CZR
$6.1B
| $20.8M | 9.29% |
408,507
+42,553
| +12% | +$1.93M |
|
|
EVRI
4
DELISTED
Everi Holdings
EVRI
| $16.9M | 7.52% |
1,166,099
+7,314
| +0.6% | +$111K |
|
5
Inspired Entertainment
INSE
$188M
| $14.4M | 6.41% |
976,661
-116,541
| -11% | -$1.58M |
|
6
Burford Capital
BUR
$955M
| $11.8M | 5.27% |
970,004
+153,486
| +19% | +$1.99M |
|
|
7
Community Health Systems
CYH
$393M
| $10.9M | 4.86% |
2,476,835
+1,700,678
| +219% | +$7.24M |
|
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $10.4M | 4.65% |
+23,500
| New | +$9.86M |
|
|
ICPT
9
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.91M | 4.42% |
+896,294
| New | +$12.5M |
|
10
Fennec Pharmaceuticals
FENC
$345M
| $9.49M | 4.23% |
1,074,654
-175,442
| -14% | -$1.46M |
|
|
11
VEON
VEON
$3.57B
| $9.04M | 4.03% |
442,032
+155,279
| +54% | +$3M |
|
|
12
PUT
Caesars Entertainment
CZR
$6.1B
| $7.9M | 3.52% |
+155,000
| New | +$7.04M |
|
|
AMRN
13
Amarin Corp
AMRN
$293M
| $6.51M | 2.91% |
273,738
| – | – |
|
|
14
Turning Point Brands
TPB
$1.56B
| $6.14M | 2.74% |
255,644
-235,496
| -48% | -$5.3M |
|
|
15
FerroAtlántica
GSM
$628M
| $5.69M | 2.54% |
1,193,367
+696,545
| +140% | +$3.2M |
|
|
ATSG
16
DELISTED
Air Transport Services Group
ATSG
| $5.51M | 2.46% |
+291,787
| New | +$5.43M |
|
|
17
CALL
Caesars Entertainment
CZR
$6.1B
| $5.1M | 2.27% |
+100,000
| New | +$4.54M |
|
|
18
CALL
Burford Capital
BUR
$955M
| $4.87M | 2.17% |
400,000
+295,600
| +283% | +$3.83M |
|
|
19
Anterix
ATEX
$1.78B
| $4.08M | 1.82% |
128,672
-80,195
| -38% | -$2.59M |
|
|
20
United Therapeutics
UTHR
$26.1B
| $3.66M | 1.63% |
16,580
-36,700
| -69% | -$8.13M |
|
|
SUM
21
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.84M | 1.27% |
75,135
-283,524
| -79% | -$8.78M |
|
22
American Coastal Insurance
ACIC
$526M
| $1.53M | 0.68% |
+343,547
| New | +$1.48M |
|
23
Aware
AWRE
$24.2M
| $1.42M | 0.63% |
896,676
+12,751
| +1% | +$21K |
|
|
24
CALL
United Therapeutics
UTHR
$26.1B
| $1.32M | 0.59% |
+6,000
| New | +$1.33M |
|
25
Sphere Entertainment
SPHR
$5.06B
| $1.09M | 0.49% |
+39,818
| New | +$1.32M |
|
Similar funds
ECH
CWM
AFA
BCM
VSI
ISFAN
JHWEPV
CCG
DG Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, DG Capital Management held 41 positions worth $224M, up 26% from $178M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
DG Capital Management deployed $30.3M of net new capital in Q2 2023, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 896,294 shares worth $9.91M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Summit Materials, Inc. Class A Common Stock, an estimated $8.78M trimmed.
- DG Capital Management's largest Q2 2023 buy was Intercept Pharmaceuticals, Inc.: 896,294 shares worth $9.91M.
- DG Capital Management added most to Community Health Systems in Q2 2023, an estimated $7.24M increase.
- DG Capital Management's biggest Q2 2023 reduction was Summit Materials, Inc. Class A Common Stock, cutting an estimated $8.78M.
- DG Capital Management fully exited State Street SPDR S&P Regional Banking ETF in Q2 2023, selling an estimated $1.32M.
- DG Capital Management's ten largest holdings make up 67% of its $224M portfolio in Q2 2023.
- DG Capital Management opened 11 new positions and closed 5 in Q2 2023.
- DG Capital Management's portfolio value rose 26% quarter-over-quarter to $224M.
Based on DG Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.